ArticleFrontiers in oncology2025

To explore the potential of LOXL2 as a biomarker in glioma and construct a genomic integrated clinical prognostic model.

Hongjuan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.